Nanobiotix
French healthcare company
Nanobiotix is a biotechnology company. It uses nanomedicine to develop new radiotherapy techniques for cancer patients. The home office of the company is in Paris. Also, it has offices in New York and Massachusetts.
 | |
| Euronext: NANO | |
| Industry | Biotechnology |
| Founded | 2003 |
| Headquarters | Paris, France |
Key people | Laurent Levy ( CEO) |
| Products | NBTXR3 (Hensify®) |
| €2.54 million (2019) | |
| Total assets | €54.9 million (2019) |
Number of employees | 110 (2020) |
| Website | www.nanobiotix.com |
Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
